Catalent Pharma Solutions News and Activities
Presence
Catalent Pharma Solutions provides development, manufacturing, and delivery services for medicines and health products. Its main offerings include drug production, biologics support, clinical supply services, and consumer health products for pharmaceutical and biotech companies.
Catalent Pharma Solutions products and services overview:
- Drug development
- Drug manufacturing
- Biologics services
- Clinical supplies
- Consumer health
- Delivery technologies
Revenue: ~$4 billion
Employees: 18,000
Headquarters: Somerset, United States (USA)
Catalent Pharma Solutions is one of the...
Catalent Pharma Solutions is a company listed under the stock ticker CTLT (US).
Catalent Pharma Solutions has a direct presence in 2 countries.Catalent Pharma Solutions has 3 subsidiaries including Catalent Biologics, Catalent Cell & Gene Therapy and Catalent Pharma Germany.
They are in:
- Pharmaceuticals50%
- Biotechnology50%
Executives
View the org chart displaying its 38 main executives
Most searched biographies at Catalent Pharma Solutions
- Alessandro Maselli, President and Chief Executive Officer
- Jonathan Levy, Director
- Charles Patten, Director
Create your alert
to follow the executive moves at Catalent Pharma Solutions.
Pharmaceuticals
Catalent Pharma Solutions has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Catalent Pharma Solutions
- Catalent and Elpida Therapeutics Enter Strategic Partnership for Late-Phase AAV Manufacturing
- Cartherics and Catalent Expand Commercial License Agreement
- Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases
- Catalent and S.Biomedics Announce Partnership to Develop and Manufacture TED‑A9
- SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs
- Catalent’s SMARTag®ADC Pipeline and New Enhanced Conjugates Offering Featured at 16th World ADC San Diego
- Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by “Championing the Missions that Matter™”
- Catalent Announces Opening of its New Global Corporate Headquarters in Tampa, Florida
- Catalent Announces New Board Appointments
- Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S.
- View more press releases Close
Social media about Catalent Pharma Solutions
- Catalent Pharma Solutions on Wikipedia, Google News & Yahoo Finance
- Catalent Pharma Solutions on LinkedIn, X (Twitter) & YouTube
